An exploratory algorithm to identify intra-host recombinant viral sequences.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 2615825)

Published in Mol Phylogenet Evol on August 31, 2008

Authors

Marco Salemi1, Rebecca R Gray, Maureen M Goodenow

Author Affiliations

1: Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, College of Medicine, 1376 Mowry Road, P.O. Box 106633, Gainesville, FL 32610, USA. salemi@pathology.ufl.edu

Articles citing this

An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol (2009) 3.11

Phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis. PLoS One (2013) 1.79

Testing spatiotemporal hypothesis of bacterial evolution using methicillin-resistant Staphylococcus aureus ST239 genome-wide data within a bayesian framework. Mol Biol Evol (2010) 1.34

Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreaks. PLoS Negl Trop Dis (2013) 1.27

Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology. PLoS One (2009) 1.08

Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol (2010) 1.07

HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations. PLoS One (2011) 1.05

Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma. PLoS One (2009) 0.97

Short term evolution of a highly transmissible methicillin-resistant Staphylococcus aureus clone (ST228) in a tertiary care hospital. PLoS One (2012) 0.88

Multiple independent lineages of HIV-1 persist in breast milk and plasma. AIDS (2011) 0.88

Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineages. Retrovirology (2014) 0.86

Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques. J Virol (2015) 0.86

The intra-host evolutionary and population dynamics of human immunodeficiency virus type 1: a phylogenetic perspective. Infect Dis Rep (2013) 0.86

Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects. J Virol (2012) 0.85

Analysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by ultradeep pyrosequencing. J Virol (2014) 0.83

Evolution of endogenous retroviruses in the Suidae: evidence for different viral subpopulations in African and Eurasian host species. BMC Evol Biol (2011) 0.80

HIV-miR-H1 evolvability during HIV pathogenesis. Biosystems (2010) 0.77

Daily sampling of an HIV-1 patient with slowly progressing disease displays persistence of multiple env subpopulations consistent with neutrality. PLoS One (2011) 0.77

Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission. Retrovirology (2015) 0.76

Longitudinal analysis of intra-host simian immunodeficiency virus recombination in varied tissues of the rhesus macaque model for neuroAIDS. J Gen Virol (2013) 0.76

Evolution of Neuroadaptation in the Periphery and Purifying Selection in the Brain Contribute to Compartmentalization of Simian Immunodeficiency Virus (SIV) in the Brains of Rhesus Macaques with SIV-Associated Encephalitis. J Virol (2016) 0.75

Articles cited by this

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97

Application of phylogenetic networks in evolutionary studies. Mol Biol Evol (2005) 31.72

Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol (1999) 18.82

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49

Analyzing the mosaic structure of genes. J Mol Evol (1992) 10.99

Statistical tests for detecting gene conversion. Mol Biol Evol (1989) 9.86

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02

Neighbor-net: an agglomerative method for the construction of phylogenetic networks. Mol Biol Evol (2003) 8.51

Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol (1979) 7.69

RDP: detection of recombination amongst aligned sequences. Bioinformatics (2000) 6.83

Evaluation of methods for detecting recombination from DNA sequences: computer simulations. Proc Natl Acad Sci U S A (2001) 6.72

A simple and robust statistical test for detecting the presence of recombination. Genetics (2006) 6.71

Automated phylogenetic detection of recombination using a genetic algorithm. Mol Biol Evol (2006) 5.94

Consequences of recombination on traditional phylogenetic analysis. Genetics (2000) 5.01

GARD: a genetic algorithm for recombination detection. Bioinformatics (2006) 4.88

Intraspecific gene genealogies: trees grafting into networks. Trends Ecol Evol (2001) 4.61

Recombination: Multiply infected spleen cells in HIV patients. Nature (2002) 4.38

Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A (2004) 4.37

Reconstructing evolution of sequences subject to recombination using parsimony. Math Biosci (1990) 4.07

A program for calculating and displaying compatibility matrices as an aid in determining reticulate evolution in molecular sequences. Comput Appl Biosci (1996) 3.11

Pervasive genomic recombination of HIV-1 in vivo. Genetics (2004) 2.79

Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50

Understanding the genetic diversity of HIV-1. AIDS (2000) 2.39

Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog (2007) 2.38

Phylogenetic profiles: a graphical method for detecting genetic recombinations in homologous sequences. Mol Biol Evol (1998) 2.36

Evaluation of methods for detecting recombination from DNA sequences: empirical data. Mol Biol Evol (2002) 2.36

Coalescent estimates of HIV-1 generation time in vivo. Proc Natl Acad Sci U S A (1999) 2.02

A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol (2004) 1.87

Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J Virol (1995) 1.80

A simulation study of the reliability of recombination detection methods. Mol Biol Evol (2001) 1.79

Recombination following superinfection by HIV-1. AIDS (2004) 1.57

Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination. J Virol (2005) 1.53

Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS. J Virol (2002) 1.50

Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections. J Virol (2007) 1.37

Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. J Virol (1999) 1.23

Network analysis of human and simian immunodeficiency virus sequence sets reveals massive recombination resulting in shorter pathways. J Gen Virol (2003) 1.17

A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. AIDS Res Hum Retroviruses (2001) 1.04

HIV-1 intra-subtype superinfection rates: estimates using a structured coalescent with recombination. Infect Genet Evol (2005) 1.03

Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch. J Virol (2007) 0.95

Sliding MinPD: building evolutionary networks of serial samples via an automated recombination detection approach. Bioinformatics (2007) 0.85

Identification of CRF10_CD viruses among bar and hotel workers in Moshi, Northern Tanzania. AIDS Res Hum Retroviruses (2005) 0.85

Articles by these authors

Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. AIDS (2009) 1.91

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS (2010) 1.79

Unifying the spatial epidemiology and molecular evolution of emerging epidemics. Proc Natl Acad Sci U S A (2012) 1.52

Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity. J Leukoc Biol (2011) 1.41

Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children. AIDS Res Hum Retroviruses (2002) 1.36

High-resolution molecular epidemiology and evolutionary history of HIV-1 subtypes in Albania. PLoS One (2008) 1.30

A novel methodology for large-scale phylogeny partition. Nat Commun (2011) 1.29

Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease. Biochemistry (2004) 1.28

HIV-1 activates macrophages independent of Toll-like receptors. PLoS One (2008) 1.26

Retroviral proteases. Genome Biol (2002) 1.17

Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology (2009) 1.16

Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology (2005) 1.15

Phylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispecies. PLoS One (2007) 1.15

Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N. Biochemistry (2003) 1.15

HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol (2010) 1.12

Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics (2004) 1.11

Haplotype-based study of the association of alcohol-metabolizing genes with alcohol dependence in four independent populations. Alcohol Clin Exp Res (2010) 1.11

Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir. Biochemistry (2006) 1.11

The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. AIDS Res Hum Retroviruses (2008) 1.07

Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages. J Virol (2005) 1.04

The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C protease. Biochemistry (2007) 1.04

Spatial accessibility and the spread of HIV-1 subtypes and recombinants. AIDS (2012) 1.03

Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1. J Virol (2004) 1.02

Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages. J Leukoc Biol (2003) 1.01

Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges. Sci Rep (2013) 1.01

Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response. Virology (2008) 1.01

High-resolution phylogenetics and phylogeography of human immunodeficiency virus type 1 subtype C epidemic in South America. J Gen Virol (2011) 0.99

Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma. PLoS One (2009) 0.97

Linkage disequilibrium and association analysis of alpha-synuclein and alcohol and drug dependence in two American Indian populations. Alcohol Clin Exp Res (2007) 0.93

High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems. Retrovirology (2012) 0.93

Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children. J Infect Dis (2003) 0.92

Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells. J Allergy Clin Immunol (2008) 0.91

Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy. AIDS Res Hum Retroviruses (2011) 0.90

High-resolution structure of unbound human immunodeficiency virus 1 subtype C protease: implications of flap dynamics and drug resistance. Acta Crystallogr D Biol Crystallogr (2008) 0.90

13. HIV-1 infection. J Allergy Clin Immunol (2003) 0.89

Significant genetic heterogeneity of the SIVmac251 viral swarm derived from different sources. AIDS Res Hum Retroviruses (2011) 0.89

Efficient transmission and persistence of low-frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology. J Gen Virol (2012) 0.89

Multiple independent lineages of HIV-1 persist in breast milk and plasma. AIDS (2011) 0.88

IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan. Cell Immunol (2010) 0.87

Unexpected maintenance of hepatitis C viral diversity following liver transplantation. J Virol (2012) 0.86

Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor. AIDS (2009) 0.85

Antiretroviral therapy restores diversity in the T-cell receptor Vbeta repertoire of CD4 T-cell subpopulations among human immunodeficiency virus type 1-infected children and adolescents. Clin Vaccine Immunol (2009) 0.85

Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents. AIDS Res Hum Retroviruses (2004) 0.84

Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection. J Neuroimmune Pharmacol (2014) 0.83

Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages. J Leukoc Biol (2010) 0.83

Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061. J Acquir Immune Defic Syndr (2015) 0.83

High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch. Infect Genet Evol (2013) 0.81

Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.80

PhyloTempo: A Set of R Scripts for Assessing and Visualizing Temporal Clustering in Genealogies Inferred from Serially Sampled Viral Sequences. Evol Bioinform Online (2012) 0.80

Virology: The virus whose family expanded. Nature (2013) 0.79

HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005. AIDS Res Ther (2012) 0.78

The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation. J Leukoc Biol (2012) 0.78

HPV-QUEST: A highly customized system for automated HPV sequence analysis capable of processing Next Generation sequencing data set. Bioinformation (2012) 0.77

Longitudinal analysis of intra-host simian immunodeficiency virus recombination in varied tissues of the rhesus macaque model for neuroAIDS. J Gen Virol (2013) 0.76